COVID-19 can infect the eyes, most commonly causing a form of conjunctivitis that looks and feels much like ordinary pink eye. Roughly one in ten hospitalized COVID patients develops some kind of eye symptom, and the virus’s entry receptors have been found across the surface of the human eye. But the picture extends well beyond red, watery eyes: deeper structures like the retina, optic nerve, and uvea can also be affected, and some people develop lingering eye problems months after their initial infection.
Why the Eye Is Vulnerable
SARS-CoV-2 enters human cells by latching onto a protein called ACE2 and using a second protein, TMPRSS2, to complete the process. Both of these proteins are present on the outer surface of the eye. Immunohistochemical analysis has confirmed ACE2 and TMPRSS2 in the conjunctiva (the membrane lining the eyelids and white of the eye), the limbus (where the cornea meets the white), and the cornea itself, with the strongest expression in the outermost layers of tissue that are directly exposed to the environment.1PubMed Central. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection A separate gene-expression study corroborated this, finding that the co-expression of ACE2 and TMPRSS2 was concentrated in the superficial epithelium of adult conjunctival, limbal, and corneal tissue.2PubMed Central. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface
This matters because it means the virus does not just irritate the eye secondarily during a respiratory infection. It has a direct molecular foothold on eye tissue. Lab work on conjunctival and pterygium cell lines showed ACE2 expression at levels comparable to lung cells, though TMPRSS2 expression was more variable across cell types.3Eye. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea So the eye surface is genuinely susceptible, even if it gets infected far less often than the nose or throat.
Conjunctivitis as the Most Common Eye Symptom
When COVID does affect the eyes, the typical presentation is conjunctivitis: redness, watering, a gritty or burning sensation, and sometimes mild discharge. A study of 302 hospitalized COVID patients found acute conjunctivitis in about 12% of cases, with no clear link to how severe the patient’s overall illness was.4PubMed Central. Conjunctivitis in COVID-19 patients: frequency and clinical presentation Another study of 127 mild COVID cases reported that around 6% developed conjunctival congestion, and in a few patients the eye redness actually appeared before the more recognizable respiratory symptoms.5PubMed Central. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study
The good news is that COVID-related conjunctivitis tends to be self-limiting. It resolves on its own, does not damage vision, and rarely needs specific treatment beyond lubricating drops for comfort.6PubMed Central. Conjunctivitis in COVID-19 patients: frequency and clinical presentation Distinguishing it from bacterial or adenoviral pink eye by appearance alone is tricky. One clue that emerged from outpatient data in India is that petechial hemorrhage (tiny pinpoint bleeds on the conjunctiva) was noted in about a third of patients with SARS-CoV-2-associated conjunctivitis, whereas subepithelial infiltrates, a hallmark of adenoviral infection, were absent.7PubMed Central. Outpatient human coronavirus associated conjunctivitis in India Still, confirming the cause usually requires testing rather than clinical appearance alone.
Can the Virus Actually Be Found in Tears?
Even when COVID patients have pink eye, viral RNA in their tears is hard to detect. One study of 40 patients found a tear positivity rate of just 2.5%, with only a single conjunctival swab testing weakly positive.8PubMed Central. SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods A separate series of 43 severe COVID patients found viral RNA in about 7% of tear samples; all patients with positive tears also tested positive on nasopharyngeal swabs, and the patient with frank conjunctivitis was among them.9Eye. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019
Post-mortem studies paint a slightly broader picture. Among eyes recovered from deceased COVID patients, SARS-CoV-2 RNA was found in about 13% of ocular tissue samples overall, and viral spike and envelope proteins were detected in the epithelial layer of corneas that had not been disinfected before collection.10PubMed Central. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues This suggests the virus can lodge in eye tissue even when it is not readily washed out in tear samples during life.
From the Eye to the Lungs
One persistent question has been whether catching the virus through the eyes can lead to a respiratory infection. The anatomy makes it plausible: your tear drainage system (the nasolacrimal duct) empties into the nasal cavity, giving anything on the eye surface a direct route into the respiratory tract. An animal experiment demonstrated exactly this pathway. Rhesus macaques inoculated with SARS-CoV-2 through the conjunctiva developed mild pneumonia within three days, and the virus was detectable along the entire nasolacrimal system from the lacrimal gland down to the throat.11PubMed Central. Evidence of SARS-CoV-2 Transmission Through the Ocular Route
Animal models have added further detail. In transgenic mice inoculated intranasally, the virus traveled from the lungs to the brain and then into the eyes along the trigeminal and optic nerves, causing retinal inflammation and elevated inflammatory markers.12PubMed Central. Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation Interestingly, when the virus was dropped directly onto the eyes in that same model, it did not cause lung infection and gradually cleared. So the eye-to-lung route seems real but is less efficient than the nose-to-lung route most people are infected through.
Deeper Eye Problems
Beyond conjunctivitis, COVID has been linked to inflammation and damage in deeper parts of the eye. These complications are rarer but more serious.
Retinal Findings
A cross-sectional study of patients who experienced acute visual impairment during COVID infection found cotton-wool spots (small, whitish patches indicating disrupted blood flow to the retinal nerve fiber layer) in over half of cases. About one in five also had scattered hemorrhagic spots around the optic disc.13Scientific Reports. A cross-sectional study of fundus lesion characteristics in patients with acute visual impairment caused by COVID-19 infection These retinal changes are thought to reflect microvascular damage similar to the clotting problems COVID causes elsewhere in the body.
Uveitis and Scleritis
Uveitis, or inflammation of the middle layer of the eye, has been reported both during and after COVID infection. A hospital-based study documented 18 patients who developed new-onset or relapsed uveitis after COVID, split evenly between first-time cases and flare-ups of pre-existing disease.14PubMed Central. New onset or recurrence of uveitis following COVID-19 infection There have also been case reports of anterior scleritis (a painful inflammation of the white of the eye) appearing weeks after COVID in patients who had no prior history of autoimmune eye disease.15PubMed Central. Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases These inflammatory complications likely reflect the immune system’s overreaction rather than direct viral invasion of deep eye tissue.
Optic Neuritis and Cranial Nerve Palsies
COVID’s neurological reach can extend to the optic nerve. A case report described a 38-year-old woman who developed sudden vision loss in one eye about three weeks after testing positive, consistent with optic neuritis.16PubMed Central. Optic Neuritis in Resolving Phase of COVID-19 Infection and Its Management: A Case Report A narrative review of neuro-ophthalmic complications catalogued additional problems including cranial nerve palsies affecting the third, fourth, sixth, and seventh nerves, papillophlebitis, and idiopathic intracranial hypertension, all of which can cause double vision, facial weakness, or visual loss.17PubMed Central. Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 and Its Vaccination: A Narrative Review These complications remain uncommon, but any sudden change in vision or eye movement during or after COVID warrants urgent evaluation.
Children and MIS-C
Pediatric COVID tends to be milder than adult disease, but a specific complication called multisystem inflammatory syndrome in children (MIS-C) stands out for its high rate of eye involvement. A systematic review found that over half of pediatric MIS-C patients had ocular manifestations, virtually all of which were non-purulent conjunctivitis: red eyes without the thick discharge typical of bacterial pink eye.18PubMed Central. Acute and sub-acute ocular manifestations in pediatric patients with COVID-19: A systematic review Because MIS-C can appear weeks after what may have been an asymptomatic infection, a child presenting with red eyes, fever, rash, and abdominal pain should be evaluated for this condition even if no one in the household had a known COVID case.
Long COVID and the Eyes
Some eye problems linger well beyond the acute infection. A growing body of evidence points to damage to the tiny nerve fibers in the cornea as a lasting consequence. In one study, over 90% of recovered COVID patients examined months later showed abnormalities in their corneal subbasal nerve plexus consistent with small fiber neuropathy. More than a third reported new-onset feelings of dryness, and structural changes like beaded axons and neuroma-like formations were common.19PubMed Central. Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease The presence of these changes up to ten months after recovery suggests the damage is chronic rather than a temporary side effect.
A more recent study using confocal microscopy found that patients with persistent ocular symptoms had measurably reduced nerve density in the cornea, a weakened blink reflex, and abnormal pupil responses consistent with autonomic dysfunction. Their eyes also showed elevated levels of mature inflammatory cells in the corneal tissue, suggesting ongoing immune activation long after the virus itself had been cleared.20Nature Communications. Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy For people experiencing persistent dry eye, light sensitivity, or blurry vision after COVID, these findings point to a real underlying mechanism rather than something imagined. Conventional dry-eye treatments like preservative-free artificial tears may help with comfort, though the nerve damage driving symptoms takes time to resolve on its own and may benefit from closer follow-up with an eye specialist.
Did the Variant Matter?
Eye symptoms were not equally common across all SARS-CoV-2 variants. Contact tracing data from England showed that red or irritated eyes were more strongly associated with the Delta variant than with Omicron; the odds of reporting eye symptoms were about 30% lower with Omicron compared to Delta.21PubMed Central. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England A UK-based analysis reinforced this, finding that “eye soreness” was among a dozen symptoms significantly less common with Omicron infections.22The Lancet. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 variants of concern in the UK As the virus has continued to evolve, the relative frequency of eye complaints has likely shifted further, though large-scale symptom tracking for post-Omicron subvariants is thinner.
Eye Protection and Transmission Prevention
The fact that the virus can enter through the eyes raises an obvious follow-up: does wearing eye protection help? A systematic review and meta-analysis published in The Lancet found that eye protection (goggles or face shields) was associated with roughly 78% lower odds of infection compared to no eye protection, based on adjusted estimates.23The Lancet. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis A separate systematic review looking specifically at SARS-CoV-2 found odds ratios ranging widely across studies, from about a 40% to a 96% relative risk reduction with eye protection, though none of the studies adjusted well for other protective behaviors, and the overall certainty of evidence was rated very low.24PubMed Central. The effect of eye protection on SARS-CoV-2 transmission: a systematic review
In practice, universal eye protection never became a standard public health recommendation the way masks did. For healthcare workers in high-risk settings, face shields or goggles were part of recommended personal protective equipment early in the pandemic and remain so during aerosol-generating procedures. For the general public, the evidence suggests eye protection offers some benefit but is probably less critical than a well-fitted respirator, since the eyes represent a much smaller exposure surface than the nose and mouth.
Contact Lenses During COVID
Early in the pandemic, many contact lens wearers worried that their lenses might increase infection risk, since inserting and removing them involves touching the eyes. A survey of Spanish lens wearers found that about 40% were concerned about increased risk, and nearly half stopped wearing their lenses entirely during pandemic lockdowns.25PubMed Central. Influence of the COVID-19 pandemic on contact lens wear in Spain The silver lining: the pandemic improved hand hygiene among those who kept wearing lenses. A large survey found that handwashing and hand disinfection before lens handling were reported significantly more often in April 2020 compared to February 2020.26PubMed Central. Microbial Keratitis Before, During and After the COVID-19 Pandemic, and the Role of Contact Lens Wear and Hand Hygiene
No strong evidence ever emerged that contact lens wear itself increased the risk of COVID eye infection. The concern was always about hand-to-eye contact rather than the lens material. If you wash your hands thoroughly before handling lenses and follow standard lens hygiene, the risk from wearing contacts during a respiratory virus outbreak is not meaningfully different from not wearing them.
Vaccine-Associated Eye Inflammation
An issue that gets less attention than infection-related eye problems is uveitis following COVID vaccination. A large cohort study of people with a history of uveitis found that about 9% experienced a uveitis episode within three months of vaccination, and the rate climbed to roughly 17% by one year. The risk was highest in the first few weeks after the shot, with an early-onset hazard ratio of about 1.64 compared to the pre-vaccination baseline, and a smaller but persistent elevation in the delayed period.27JAMA Ophthalmology. COVID-19 Vaccine–Associated Uveitis in Patients With a History of Uveitis This study focused specifically on people who already had a uveitis history, so these numbers do not apply to the general population. For most people, the absolute risk of post-vaccine uveitis is very low. But if you have a known history of uveitis, it is worth discussing the timing of vaccinations with your ophthalmologist so you can monitor for flare-ups.
It is also worth putting this in context: COVID infection itself triggers uveitis, as discussed earlier, and the inflammatory cascade from actual disease is generally harder on the body than the vaccine-triggered immune response. The choice is not between a risk and no risk; it is between a smaller, more predictable risk from vaccination and a larger, less predictable one from unvaccinated infection.
When to See an Eye Doctor
Mild conjunctivitis during a COVID infection usually does not require specialized care. Cool compresses and lubricating drops are typically enough to manage the discomfort, and it tends to clear within a week or two. You should seek evaluation from an ophthalmologist if you experience any of the following during or after a COVID infection:
- Sudden vision loss: could indicate optic neuritis, retinal vascular occlusion, or other serious involvement.
- Persistent eye pain: pain as opposed to irritation may suggest scleritis, uveitis, or elevated eye pressure.
- Double vision: might reflect cranial nerve palsy affecting the muscles that move the eyes.
- Light sensitivity that worsens: a common sign of intraocular inflammation like uveitis.
- Lingering dryness or blurred vision: lasting more than a few weeks after recovery, this could reflect corneal nerve damage and may benefit from targeted treatment.
The threshold for concern is lower in children with red eyes and systemic symptoms like fever and rash, given the association between non-purulent conjunctivitis and MIS-C. When in doubt, an urgent evaluation can rule out the more serious possibilities quickly.